Evidence map›Paper›PMID 32947271›Full record

ArticlePhysiological measurement2020

Remote health diagnosis and monitoring in the time of COVID-19.

Joachim A Behar, Chengyu Liu, Kevin Kotzen, Kenta Tsutsui, Valentina D A Corino, Janmajay Singh, Marco A F Pimentel, Philip Warrick, Sebastian Zaunseder, Fernando Andreotti and 6 more

Abstract read
In one paragraph

Article in Physiological measurement, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The 2023 wearable photoplethysmography roadmap.Physiological measurement · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Review on the COVID-19 pandemic prevention and control system based on AI.Engineering applications of artificial intelligence · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Joachim A BeharFaculty of Biomedical Engineering, Technion-IIT, Haifa, Israel.ORCID 0000-0001-5956-7034
Chengyu LiuThe State Key Laboratory of Bioelectronics, School of Instrument Science and Engineering, Southeast University, Nanjing, People's Republic of China.
Kevin KotzenFaculty of Biomedical Engineering, Technion-IIT, Haifa, Israel.
Kenta TsutsuiDepartment of Cardiovascular Medicine, Saitama Medical University International Medical Center, Saitama, Japan.ORCID 0000-0002-5121-6974
Valentina D A CorinoDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Italy.
Janmajay SinghIndependent researcher, Japan.
Marco A F PimentelDepartment of Engineering Science, University of Oxford, Oxford, United Kingdom.
Philip WarrickPeriGen, Cary, NC, and Westmount, QC, Canada.
Sebastian ZaunsederFaculty of Information Technology, FH Dortmund, Dortmund, Germany.
Fernando AndreottiSensyne Health, Oxford, United Kingdom.
David SebagIndependent physician, Grenoble, France.
Georgy KopanitsaITMO University, Saint Petersburg, Russia.ORCID 0000-0002-6231-8036
Patrick E McSharryCarnegie Mellon University Africa, Kigali, Rwanda.
Walter KarlenMobile Health Systems Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0001-8643-3074
Chandan KarmakarSchool of Information Technology, Deakin University, Geelong, Australia.ORCID 0000-0003-1814-0856
Gari D CliffordDepartment of Biomedical Informatics, Emory University, Atlanta, GA, United States of America.ORCID 0000-0002-5709-201X

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
NCATS NIH HHS UL1 TR002378
6 · The paper itself

Abstract

Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. The clinical spectrum of SARS-CoV-2 pneumonia requires early detection and monitoring, within a clinical environment for critical cases and remotely for mild cases, with a large spectrum of symptoms. The fear of contamination in clinical environments has led to a dramatic reduction in on-site referrals for routine care. There has also been a perceived need to continuously monitor non-severe COVID-19 patients, either from their quarantine site at home, or dedicated quarantine locations (e.g. hotels). In particular, facilitating contact tracing with proximity and location tracing apps was adopted in many countries very rapidly. Thus, the pandemic has driven incentives to innovate and enhance or create new routes for providing healthcare services at distance. In particular, this has created a dramatic impetus to find innovative ways to remotely and effectively monitor patient health status. In this paper, we present a review of remote health monitoring initiatives taken in 20 states during the time of the pandemic. We emphasize in the discussion particular aspects that are common ground for the reviewed states, in particular the future impact of the pandemic on remote health monitoring and consideration on data privacy.

Indexed as

Coronavirus InfectionsCOVID-19HumansMonitoring, PhysiologicPandemicsPneumonia, ViralTelemedicine

Identifiers

PMID32947271
PMCPMC9364387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.